Signal Amplification Strategies and Advances in CRISPR/Cas Molecular Diagnostics

Main Article Content

Yumo Ding
Wenzhou Medical University, School of Laboratory Medicine and Life Science, Wenzhou Zhejiang 325027

DOI: https://doi.org/10.70267/emsgh.v3.132140

Keywords

CRISPR/Cas, molecular diagnostics, signal amplification strategies, one-tube assays, nucleic acid testing, Cas12a/Cas13a

Abstract

Accurate detection of infectious diseases and serious diseases is of great importance to public health. CRISPR/Cas has become a highly sensitive and specific molecular diagnostic tool with its programmable recognition and trans-cleavage activity. This article reviews its classification and mechanisms, nucleic acid detection principle, signal amplification strategy, one-tube detection and clinical translation. It is pointed out that pre-amplification coupling, amplification free enhancement and system optimization can significantly improve the sensitivity. One-tube strategies such as physical isolation, glycerol separation, light control, and suboptimal PAM can alleviate aerosol contamination and problems with amplification compatibility, but multiplexing throughput, sample interference, and POCT integration still constrain clinical translation. This study provides a reference for the optimization of CRISPR molecular diagnosis and “sample-in, result-out” application.

Abstract 17 | PDF Downloads 10

References

  • [1]Gootenberg, J. S., Abudayyeh, O. O., Lee, J. W., Essletzbichler, P., Dy, A. J., Joung, J., Verdine, V., Donghia, N., Daringer, N. M., Freije, C. A., Myhrvold, C., Bhattacharyya, R. P., Livny, J., Regev, A., Koonin, E. V., Hung, D. T., Sabeti, P. C., Collins, J. J., & Zhang, F. (2017). Nucleic acid detection with CRISPR-Cas13a/C2c2. Science, 356(6336), 438–442. https://doi.org/10.1126/science.aam9321
  • [2]Wang, K., Yu, Y., Yang, T., Lei, C., & Wu, H. (2026). Research progress of CRISPR-Cas molecular diagnostic technology and its clinical detection (in Chinese). Journal of Instrumental Analysis, 45(3), 664–672.
  • [3]Chen, J. S., Ma, E., Harrington, L. B., Da Costa, M., Tian, X., Palefsky, J. M., & Doudna, J. A. (2018). CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity. Science, 360(6387), 436–439. https://doi.org/10.1126/science.aar6245
  • [4]Tang, J., & Peng, J. (2026). Research progress on amplification-free CRISPR/Cas nucleic acid detection technology (in Chinese). Scientia Sinica Vitae.
  • [5]Kaminski, M. M., Abudayyeh, O. O., Gootenberg, J. S., Zhang, F., & Collins, J. J. (2021). CRISPR-based diagnostics. Nature Biomedical Engineering, 5(7), 643–656. https://doi.org/10.1038/s41551-021-00760-7
  • [6]Wang, M., Pan, J., Yao, Z., & Luo, S. (2026). Advances in the application of CRISPR/Cas12a combined with signal amplification strategies in medical biosensing (in Chinese). Chinese Youjiang Medical Journal.
  • [7]Zhao, Z., & Peng, J. (2023). Research progress of CRISPR/Cas nucleic acid detection technology (in Chinese). Scientia Sinica Vitae, 53(8), 1–19.
  • [8]Harrington, L. B., Burstein, D., Chen, J. S., Paez-Espino, D., Ma, E., Witte, I. P., Cofsky, J. C., Kyrpides, N. C., Banfield, J. F., & Doudna, J. A. (2018). Programmed DNA destruction by miniature CRISPR-Cas14 enzymes. Science, 362(6416), 839–842. https://doi.org/10.1126/science.aav4294
  • [9]Chen, H., Song, F., Wang, B., Huang, H., Luo, Y., Han, X., He, H., Lin, S., Wan, L., Huang, Z., Fu, Z., Ledesma-Amaro, R., Yin, D., Mao, H., He, L., Yang, T., Chen, Z., Ma, Y., Xue, E. Y., & Mao, C. (2025). Ultrasensitive detection of clinical pathogens through a target-amplification-free collateral-cleavage-enhancing CRISPR-CasΦ tool. Nature Communications, 16, Article 3929. https://doi.org/10.1038/s41467-025-59219-x
  • [10]Yoshimi, K., Takeshita, K., Yamayoshi, S., Shibumura, S., Yamauchi, Y., Yamamoto, M., Yotsuyanagi, H., Kawaoka, Y., & Mashimo, T. (2022). CRISPR-Cas3-based diagnostics for SARS-CoV-2 and influenza virus. iScience, 25(2), Article 103830. https://doi.org/10.1016/j.isci.2022.103830
  • [11]Zhang, J., Yu, Y., Qi, J., & He, H. (2026). Application advances of CRISPR-Cas trans-cleavage technology in multiplex nucleic acid detection of animal pathogens (in Chinese). Biotechnology Bulletin, 42(11), 1–11.
  • [12]Lin, M. (2025). Research on a novel nucleic acid detection method based on CRISPR-Cas12a cis and trans cleavage (Doctoral dissertation, South China Normal University). CNKI. (in Chinese)
  • [13]Wu, Z., Jin, F., Zhu, W., Zhong, W., Qi, T., Luo, S., Liu, Q., Cai, Z., Dai, C., Chai, Z., He, Y., Rui, Y., Miao, Y., Zheng, L., & Fu, Q. (2026). Photoactivated digital recombinase polymerase amplification/CRISPR-Cas12a assay for point-of-care of BK polyomavirus quantification. ACS Nano, 20(17), 13301–13313. https://doi.org/10.1021/acsnano.6c02651
  • [14]Shi, K., Xie, S., Tian, R., Wang, S., Lu, Q., Gao, D., Lei, C., Zhu, H., & Nie, Z. (2021). A CRISPR-Cas autocatalysis-driven feedback amplification network for supersensitive DNA diagnostics. Science Advances, 7(5), Article eabc7802. https://doi.org/10.1126/sciadv.abc7802
  • [15]Joung, J., Ladha, A., Saito, M., Kim, N.-G., Woolley, A. E., Segel, M., Barretto, R. P. J., Ranu, A., Macrae, R. K., Faure, G., Ioannidi, E. I., Krajeski, R. N., Bruneau, R., Huang, M.-L. W., Yu, X. G., Li, J. Z., Walker, B. D., Hung, D. T., Greninger, A. L., . . . Zhang, F. (2020). Detection of SARS-CoV-2 with SHERLOCK one-pot testing. New England Journal of Medicine, 383(15), 1492–1494. https://doi.org/10.1056/nejmc2026172
  • [16]Lin, M., Yue, H., Tian, T., Xiong, E., Zhu, D., Jiang, Y., & Zhou, X. (2022). Glycerol additive boosts 100-fold sensitivity enhancement for one-pot RPA-CRISPR/Cas12a assay. Analytical Chemistry, 94(23), 8277–8284. https://doi.org/10.1021/acs.analchem.2c00616
  • [17]Hu, M., Qiu, Z., Bi, Z., Tian, T., Jiang, Y., & Zhou, X. (2022). Photocontrolled crRNA activation enables robust CRISPR-Cas12a diagnostics. Proceedings of the National Academy of Sciences, 119(26), Article e2202034119. https://doi.org/10.1073/pnas.2202034119
  • [18]Hu, M., Liu, R., Qiu, Z., Cao, F., Tian, T., Lu, Y., Jiang, Y., & Zhou, X. (2023). Light-start CRISPR-Cas12a reaction with caged crRNA enables rapid and sensitive nucleic acid detection. Angewandte Chemie International Edition, 62(23), Article e202300663. https://doi.org/10.1002/anie.202300663
  • [19]Xu, X. (2023). Research on single-tube molecular diagnostic technology based on CRISPR/Cas system (in Chinese) [Thesis]. Shenzhen University.
  • [20]Myhrvold, C., Freije, C. A., Gootenberg, J. S., Abudayyeh, O. O., Metsky, H. C., Durbin, A. F., Kellner, M. J., Tan, A. L., Paul, L. M., Parham, L. A., Garcia, K. F., Barnes, K. G., Chak, B., Mondini, A., Nogueira, M. L., Isern, S., Michael, S. F., Lorenzana, I., Yozwiak, N. L., . . . Sabeti, P. C. (2018). Field-deployable viral diagnostics using CRISPR-Cas13. Science, 360(6387), 444–448. https://doi.org/10.1126/science.aas8836
  • [21]Ackerman, C. M., Myhrvold, C., Thakku, S. G., Freije, C. A., Metsky, H. C., Yang, D. K., Ye, S. H., Boehm, C. K., Kosoko-Thoroddsen, T.-S. F., Kehe, J., Nguyen, T. G., Carter, A., Kulesa, A., Barnes, J. R., Dugan, V. G., Hung, D. T., Blainey, P. C., & Sabeti, P. C. (2020). Massively multiplexed nucleic acid detection with Cas13. Nature, 582(7811), 277–282. https://doi.org/10.1038/s41586-020-2279-8
  • [22]Dong, J., Li, X., Deng, L., Zhou, S., Hou, J., Hou, C., & Huo, D. (2024). CRISPR/Cas12a cleavage-mediated isothermal amplification lights up the dimeric G-quadruplex signal unit for ultrasensitive and label-free detection of circulating tumor DNA. Sensors and Actuators B: Chemical, 404, Article 135292. https://doi.org/10.1016/j.snb.2024.135292
  • [23]Peng, S., Tan, Z., Chen, S., Lei, C., & Nie, Z. (2020). Integrating CRISPR-Cas12a with a DNA circuit as a generic sensing platform for amplified detection of microRNA. Chemical Science, 11(28), 7362–7368. https://doi.org/10.1039/d0sc03084h
  • [24]Jia, Z., Maghaydah, Y., Zdanys, K., Kuchel, G. A., Diniz, B. S., & Liu, C. (2024). CRISPR-powered aptasensor for diagnostics of Alzheimer’s disease. ACS Sensors, 9(1), 398–405. https://doi.org/10.1021/acssensors.3c02167
  • [25]Tang, Y., Song, T., Gao, L., Yin, S., Ma, M., Tan, Y., Wu, L., Yang, Y., Wang, Y., Lin, T., & Li, F. (2022). A CRISPR-based ultrasensitive assay detects attomolar concentrations of SARS-CoV-2 antibodies in clinical samples. Nature Communications, 13, Article 4667. https://doi.org/10.1038/s41467-022-32371-4
  • [26]Liang, M., Li, Z., Wang, W., Liu, J., Liu, L., Zhu, G., Karthik, L., Wang, M., Wang, K.-F., Wang, Z., Yu, J., Shuai, Y., Yu, J., Zhang, L., Yang, Z., Li, C., Zhang, Q., Shi, T., Zhou, L., . . . Zhang, L.-X. (2019). A CRISPR-Cas12a-derived biosensing platform for the highly sensitive detection of diverse small molecules. Nature Communications, 10, Article 3672. https://doi.org/10.1038/s41467-019-11648-1
  • [27]Huang, Z., Lyon, C. J., Wang, J., Lu, S., & Hu, T. Y. (2023). CRISPR assays for disease diagnosis: Progress to and barriers remaining for clinical applications. Advanced Science, 10(20), Article 2301697. https://doi.org/10.1002/advs.202301697
  • [28]Zhao, Z., Zhao, L., & Wang, X. (2025). Research and application of nucleic acid detection and microfluidics point-of-care detection technology based on CRISPR biosensing (in Chinese). Progress in Chemistry, 37(10), 1397–1409.
  • [29]Wang, X., & He, N. (2024). Systematic review of CRISPR detection technology applied in point-of-care nucleic acid testing (in Chinese). Chinese Journal of Disease Control and Prevention, 28(11), 1344–1348.
  • [30]Zhang, Y., & Xu, J. (2025). Research progress of molecular diagnostic point-of-care testing (in Chinese). Laboratory Medicine and Clinic, 22(20), 2875–2880.
  • [31]Qiu, Z. (2026). Research on key technologies and systems of CRISPR nucleic acid detection for point-of-care testing (POCT) (in Chinese) [Doctoral dissertation]. South China Normal University.

Article Sidebar

Full Text
PDF
Information
Copy Publication Information
Published
Nov 5, 2026
Issue
Vol. 3 (2026)
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

Signal Amplification Strategies and Advances in CRISPR/Cas Molecular Diagnostics. (2026). Explore Medical Science and Global Health, 3, 132-140. https://doi.org/10.70267/emsgh.v3.132140